Search filters

List of works by Claire F. Friedman

A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)

A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers

scientific article published on 30 October 2020

BRCA Mutations, Homologous DNA Repair Deficiency, Tumor Mutational Burden, and Response to Immune Checkpoint Inhibition in Recurrent Ovarian Cancer

scientific article published on 16 June 2020

Checkpoint inhibition and melanoma: Considerations in treating the older adult

scientific article published on 11 May 2017

Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer

scientific article published on 01 August 2018

Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer

scientific article published on 19 November 2019

Combinatorial Cancer Immunotherapies

scientific article published on 12 January 2016

Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade

scientific article published on 22 November 2018

Emerging Tissue and Blood-Based Biomarkers that may Predict Response to Immune Checkpoint Inhibition.

scientific article published on April 2016

Imaging findings of immune checkpoint inhibitor associated pancreatitis

scientific article published on 29 August 2020

Machine learning-based prediction of microsatellite instability and high tumor mutation burden from contrast-enhanced computed tomography in endometrial cancers

scientific article published on 20 October 2020

Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma.

scientific article

Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial

scientific article published on 25 July 2020

Options for Adjuvant Therapy for Uterine Leiomyosarcoma

scientific article published on 8 February 2018

Ovarian cancer mutational processes drive site-specific immune evasion

scientific article published on 14 December 2022

Patient-Physician Communication in the 21st Century.

scientific article

Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma.

scientific article

Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer

scientific article published on 01 October 2020

Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY trial (CALGB 150007/150015/ACRIN6657).

scientific article

Prevalence of psychotropic medication use among cosmetic and medical dermatology patients: a comparative study

scientific article

Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer

scientific article published on 14 August 2019

Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab

scientific article published on 31 December 2016

Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors: A Review.

scientific article published on 30 June 2016

Tumor immunology and cancer immunotherapy: summary of the 2014 SITC primer.

scientific article published on 16 June 2015

Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapy

scientific article published on 02 June 2020

Vitamin d deficiency in postmenopausal breast cancer survivors

scientific article published on 2 March 2012

Paulina is supported by:

About Paulina

Help